Medtronic receives FDA approval for its next generation Micra leadless pacing systems

New pacemakers offer 40% more battery life,1 extend Medtronic legacy of pacing leadership DUBLIN, May 1, 2023 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra™…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.